Medication Labeling and Storage Deficiencies
Summary
A deficiency was cited for failure to ensure drugs and biologicals were labeled and stored according to accepted professional principles and facility policy. During medication administration to a resident with a history of atrial fibrillation, hemiplegia, hemiparesis following cerebral infarction, and long-term anticoagulant use, an LVN prepared aspirin 81 mg from a manufacturer bottle that did not display an expiration date. The LVN stated the expiration date could not be found and that the bottle would be checked later, but the aspirin was still administered during the medication pass. The DON stated the bottle should have been replaced because it did not show an expiration date and that it was not safe and effective to administer aspirin without one. A second deficiency involved the East Station Medication Room refrigerator, which was observed at 50 F while containing multiple refrigerated medications and vaccines. Items stored there included an unopened emergency kit with lorazepam, Humalog and Novolin R insulin pens, Afluria flu vaccine syringes, Humulin R insulin vials, Epogen, Ozempic pens, Prolia, Novolog Flexpens, insulin glargine pens, insulin lispro pens, a glucagon pen, and an opened tuberculin vial. The manufacturer labeling required refrigerated medications to be stored between 36 F and 46 F, while glucagon was required to be stored at room temperature. Staff stated the refrigerator temperature was out of range and that pharmacy would need to be contacted to reorder medications. The DON stated medications stored outside the recommended temperature range would not be safe and effective for residents. A third deficiency involved an opened Lantus Solostar pen for a resident with type 2 diabetes mellitus and diabetic neuropathy. The pen was found in a medication cart with an open date that placed it beyond the 28-day in-use limit required by the manufacturer. The LVN stated the insulin should have been removed from the cart because it had expired and would not be effective if administered. The resident’s MAR showed the Lantus Solostar had been administered seven times after the expiration period. The DON stated the insulin should have been removed from the cart earlier and that use of expired insulin increased the risk for hypo- or hyperglycemia.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.